Product Information
DOXYCYCLINE HYCLATE 150 MG TAB is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.7243 per EA under NDC 68180065407. Its NADAC has been published 234 times since Dec 13, 2017.
FDA first approved this application on Sep 27, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180065407
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYCYCLINE HYCLATEApproval Type
Generic (ANDA)
FDA Application
ANDA208818FDA Approved
9/27/2017
TE Code
AB
On Market Since
10/30/2017
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE HYCLATE 150 MG TAB has been published 234 times since Dec 13, 2017, and over the history we have for it it has declined 96.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7243 per EA |
|---|---|
| All-time high | $19.0539 (Oct 10, 2018) |
| All-time low | $0.6076 (Oct 23, 2024) |
| 52-week high | $0.9134 |
| 52-week low | $0.6934 |
| Median price | $10.0552 |
| Average price | $7.3513 |
| Largest weekly change | -93.7% (Jul 17, 2024) |
| Weeks tracked | 234 |
| Tracking since | Dec 13, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the doxyclycline hyclate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
doxyclycline hyclate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXYCYCLINE HYCLATE 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE HYCLATE 150 MG TAB, manufactured by Lupin Pharmaceuticals Inc., is $0.7243 per EA (NDC 68180065407), effective Sep 30, 2026.
How has the price of DOXYCYCLINE HYCLATE 150 MG TAB changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE HYCLATE 150 MG TAB has declined 96.2%. It has been tracked across 234 weekly CMS publications since Dec 13, 2017.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE HYCLATE 150 MG TAB?
Since Dec 13, 2017, the NADAC for DOXYCYCLINE HYCLATE 150 MG TAB has ranged from a low of $0.6076 (Oct 23, 2024) to a high of $19.0539 (Oct 10, 2018), with a median of $10.0552 per EA.
Are there cheaper alternatives to DOXYCYCLINE HYCLATE 150 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DOXYCYCLINE HYCLATE 150 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DOXYCYCLINE HYCLATE 150 MG TAB?
DOXYCYCLINE HYCLATE 150 MG TAB (NDC 68180065407) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.